Piskula M K, Terao J
Institute of Animal Reproduction and Food Research, 10-718 Olsztyn, Poland.
J Nutr. 1998 Jul;128(7):1172-8. doi: 10.1093/jn/128.7.1172.
Absorption of orally administered (-)-epicatechin (EC) in rats was studied to obtain plasma pharmacokinetic profiles of EC metabolites. Rats were administered 172 micromol/kg body weight of EC, and blood was collected from the tail for 8 h after administration. Seven groups of compounds possessing the basic structure of EC were identified by using a combination of enzymatic hydrolysis, HPLC and electron impact mass spectrometry. Metabolites were quantified with a new, simple and sensitive method using HPLC with electrochemical detection. Ingested EC was absorbed from the alimentary tract and was present in the rat common blood circulation in the form of glucuronide and/or sulfate conjugates. The activity of conjugative enzymes in rat tissues was studied. The highest activity of glucuronosyltransferase was found in the intestinal mucosa of both of the small and large intestine; the highest activity of phenolsulfotransferase occurred in the liver, and that of catechol-O-methyl transferase was found in the liver and kidney. It has been proposed that the first detoxification step of dietary EC, namely, glucuronidation, occurs at the level of the intestinal mucosa in rats, and EC enters the common blood circulation exclusively in the glucuronized form. The compound is then sulfated in the liver and methylated in the liver and kidney. Because ingested EC undergoes extensive conjugation, its biological activities previously demonstrated in vitro may not be occurring in in vivo systems.
为了获得(-)-表儿茶素(EC)代谢物的血浆药代动力学曲线,对大鼠口服EC的吸收情况进行了研究。给大鼠按172微摩尔/千克体重的剂量灌胃EC,给药后8小时从大鼠尾部采血。采用酶水解、高效液相色谱(HPLC)和电子轰击质谱联用的方法,鉴定出七组具有EC基本结构的化合物。采用一种新的、简单且灵敏的HPLC电化学检测法对代谢物进行定量分析。摄入的EC从消化道吸收,并以葡糖醛酸苷和/或硫酸酯共轭物的形式存在于大鼠的体循环中。研究了大鼠组织中共轭酶的活性。发现葡糖醛酸基转移酶在小肠和大肠的肠黏膜中活性最高;酚磺基转移酶在肝脏中活性最高,儿茶酚-O-甲基转移酶在肝脏和肾脏中活性最高。有人提出,膳食EC的第一步解毒反应,即葡糖醛酸化反应,发生在大鼠的肠黏膜水平,并且EC仅以葡糖醛酸化的形式进入体循环。该化合物随后在肝脏中硫酸化,并在肝脏和肾脏中甲基化。由于摄入的EC会发生广泛的共轭反应,其先前在体外所表现出的生物学活性在体内系统中可能不会出现。